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INTRODUCTION
It is now established that Helicobacter pylori (H. pylori),
which is believed to be the commonest bacterial
infection of man, is the major causative agent of
chronic gastritis.1 This chronic inflammation of  gastric
mucosa which is histologically characterized by
mucosal infiltration by plasma cells has been associated
with detectable levels of specific anti-H. pylori
antibodies of  the IgA and IgG classes.2 Helicobacter pylori
infection is usually lifelong, especially in untreated
individuals, and eventually results in atrophic changes,
gastric ulcers and cancers.3 Specific antibodies of  the
IgA class are usually detected in about two-thirds of
patients with raised IgG levels, and in a further  2-7%
of  IgG-negative patients.4
The IgA sero-prevalence of Helicobacter pylori is highly
variable from population to population. From available
literature, it appears the anti-H. pylori antibody sero-
prevalence is higher in developing countries than in
developed countries.5 This is because H. pylori infection
is associated with low socioeconomic status and low
standards of hygiene that more often characterize the
developing than the developed countries.6
Soluble cellular antigens such as urease and heat shock
protein,7-10 a vacuolating cytotoxin,11,12 and, more
recently, a 128-kDa protein (CagA) associated with
cytotoxin production13 have been suggested as possible
inducers of an inflammatory reaction in the gastric
mucosa14,15 and could explain how bacteria living in
the mucus layer can produce histological lesions in the
full thickness of the mucosa.3 In addition, it has been
suggested that intensity and specificity of  the mucosal
immune response may correlate with the level of tissue
inflammation.16
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ABSTRACT
Background: The seroprevalence of anti-H. pylori IgA antibodies has been
reported to vary among populations and in relation to strains of Helicobacter
pylori bacterium. However, there has been conflicting reports on the
association between IgA serological status and the histological variables
of chronic gastritis. This study was therefore conducted to clarify this
relationship.
Method: Using an ELISA based commercial kit, anti-H. pylori IgA antibody
tests were performed on 65 dyspeptic patients and 65 age- and sex-matched
controls. The gastric biopsies of these patients were also examined
histologically for the degrees of  inflammation, activity, intestinal metaplasia
and atrophy. The CagA status of  the patients had been determined previously.
Results: There was an anti-H. pylori IgA antibody prevalence of 67.7% in
dyspeptics and 56.9% in non-dyspeptic individuals. No correlations were
observed between serum H. pylori IgA antibody and the graded parameters
of chronic gastritis in dyspeptic patients, although twice more patients with
mild gastric inflammation were found among IgA positive than among IgA
negative patients. However, a statistically significant relationship was
established between serum IgA positivity and the CagA status of the patients
(p = 0.028).
Conclusion: The seroprevalence of anti-H. pylori IgA antibody is high in
our environment. Serum IgA status may be associated with milder degrees
of  gastritis in our patients but a larger cohort of  patients is needed to confirm
this. There seems to be a good agreement between serum IgA and CagA
statuses among dyspeptic patients.
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It has been established that subjects seropositive for
CagA protein more often have IgA antibody than
CagA negative subjects.17-21 Even though H. pylori
stimulate both local and systemic antibody responses,
the role of IgA antibody with respect to bacterial
colonization and gastric inflammation is still
controversial.
Following detailed search of  the English literature, it
seems that this is the first study in Nigeria and possibly
in sub-Saharan Africa to have evaluated the association
between anti-H. pylori IgA and histological parameters
of chronic gastritis as most sero-prevalence studies
on H. pylori in Nigeria focused on IgG levels.22-26 We
therefore investigated the anti-H. pylori IgA serology
in chronic gastritis by  determining the sero-prevalence
of H. pylori IgA antibody in dyspeptics and in the
general population and the relationship between anti-
H. pylori IgA antibody positivity and the histological
variables in chronic gastritis. We also evaluated if  the
presence of serum H. pylori IgA antibody is associated
more often with serum cag-A positive subjects than
with cag-A negative ones.
MATERIALS AND METHODS
This was a prospective study of 64 consecutive adult
patients with dyspeptic symptoms who underwent
endoscopy at the Gastrointestinal and Liver Unit of
the University College Hospital, Ibadan, Nigeria.
The patients who were previously treated for H. pylori
infection or who had received antibiotics, proton
pump inhibitors or bismuth compounds in the
preceding 4 weeks were excluded. Base line bio data
were obtained. Oesophago-gastro-duodenoscopy
(OGD) was performed on all the participants using
Olympus (GFIXQ20) or Pentax (FG29W) forward-
viewing Oesophago-gastro-duodenoscope. A
minimum of two gastric antral mucosal biopsies were
taken from each patient for histology.
The two endoscopic biopsies were fixed in 10%
formaldehyde and transferred to the histopathology
laboratory of  the hospital for processing. Four micron
thick paraffin sections were stained with routine
Haematoxylin and Eosin for the diagnosis of chronic
gastritis. Sections were examined microscopically for
the histological changes of gastritis and two of the
histological variables (degree of chronic inflammation
and activity) were graded based on the revised Sydney
System,27 while the mucosal atrophy and intestinal
metaplasia were graded as either present or absent.
Five millilitres of venous blood was collected from
all the recruited patients and 64 randomly selected age-
and sex-matched controls for IgA serology testing.
Serological analysis was performed in the serological
unit of  the Department of  Virology of  the institution.
The presence/ absence of serum anti-H. pylori IgA
antibodies to H. pylori immunodominant antigens was
determined by Enzyme Linked Immune-Sorbent
Assay (ELISA) [ (Dia.Pro Diagnostic Bioprobes srl
Milano Italy]  and the results were recorded as either
positive or negative. The CagA status of the same set
of  patients and controls had been determined
previously with a similar commercial ELISA kit.
Data were analysed using Statistical Package for Social
Sciences, version16.0 (SPSS Inc. Chicago Illinois).
Results were presented as means ± standard deviation
for quantitative variables and number (percentages) for
qualitative variables. Categorical variables were
compared with Pearson’s Chi-square. Significant P-
value was taken as <0.05.
The study was conducted in compliance with the
guidelines of the Helsinki declaration on biomedical
research in human subjects. Informed consent was
obtained and the confidentiality of the patients’ identity
and personal health information was maintained.
RESULTS
The ages of the patients ranged from 20 years to 78
years, with an average of  47.7+ 16.7 years. There were
31 males and 33 females giving a ratio of  1:1.06. Forty-
four (44) patients were sero-positive for the IgA
antibody to Helicobacter pylori while 20 were sero-










H. py lori IgA
Negative 9 7 4 20
Positive 23 16 5 44
Total 32 23 9 64
P=0.64
Table 1: Serum IgA and degree of  inflammation
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H. pylori IgA in chronic gastritis patients. However,
among the control group 37 cohorts (56.9%) were
seropositive while 27 (41.5%) were sero-negative
individuals. This difference in proportion was however
not statistically significant (P = 0.68)
The anti H. pylori IgA seropositivity/ seronegativity
ratio was greater among patients having low grade
(mild) chronic gastritis (2.6:1) when compared with
patients  having  higher grades (moderate and severe)
(moderate and severe activity, a greater percentage
elicited anti-H. pylori IgA immunological reaction
(71.4% & 70.0% respectively). However, this difference
in proportion was also not statistically significant (P =
0.94)
Only four patients were found to have intestinal
metaplasia, three of whom were IgA positive. This
histological parameter was also not significantly
associated with IgA serological status in our study.
Similarly, mucosal atrophy was not significantly
associated with serum IgA status as only three patients
were found to have mucosal atrophy on histology.
Two of  them were also IgA positive.
However, we found a significant relationship between
seropositivity for anti-H. pylori Cag-A and anti-H. pylori
IgA sero-status. Of  the 29 cag-A seropositive patients,
Neutrophilic
Infiltrate Nil Mild Moderate Severe Total
H. py lori IgA
negative 13 4 1 2 20
Positive 27 10 6 1 44
Total 40 14 7 3 64
P=0.43
Table 2: Serum IgA and Activity
Atrophy Abse nt Presen t To tal
H . py lo ri IgA
negative 19 1 20
Positive 42 2 44
Total 61 3 64
P=0.94
Table 3: Serum IgA and Mucosal atrophy
of chronic  gastritis (1.9:1). Amongst both categories
of patients having low grade (mild) chronic gastritis
and those having higher grades (moderate and severe)
chronic gastritis, a greater percentage elicited anti-H.
pylori IgA immunological reaction (71.9% & 65.6%
respectively). The ratio of subjects with lower grade
(mild) inflammation compared to higher grade
inflammation (i.e. moderate and severe inflammation)
was slightly higher in IgA positive than IgA negative
patients (1.1: 0.82). However, these differences in ratios
and proportions did not show statistical significance.
(P = 0.59)
Overall, serum IgA antibody reaction was more
frequent (61.4%) among patients without detectable
activity in relation to chronic inflammation in gastric
mucosa compared to sero-prevalence (38.6%) among
those having varying grades of  activity. This difference
in proportion was however not statistically significant
(P = 0.43). Amongst both categories of patients having
low grade (mild) activity and those having higher grades
Intestinal
metaplasia Absent Present Total
H. pylori IgA
Negative 19 1 20
Positive 41 3 44
Total 60 4 64
P=0
Table 4: Serum IgA and Intestinal Metaplasia
25 were found to be also IgA antibody positive, with
a p value of 0.028.
DISCUSSION
A major characteristic feature of H. pylori associated
chronic gastritis is the presence of mononuclear cells,
particularly plasma cells, infiltrating the lamina propria
alongside increased epithelial expression of secretory
component.28,29 The resultant local and  systemic
humoral responses to H. pylori infection may be
correlated, since eradication of H. pylori leads to
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concomitant reductions in tissue inflammation 30 and
decreases the levels of  serum antibodies.31
The high overall anti-H. pylori IgA prevalence of 56.9%
and the 67.7% among our healthy controls and
dyspeptic patients respectively, are similar to the values
found in other studies for developing countries, and
contrasts with the lower values obtained for developed
countries.6-10, 32-34 Difference in socioeconomic levels
and standards of hygiene and therefore the differences
in the prevalence of H. pylori infections have been
advanced as reason for the variation in IgA sero-
prevalence in populations. Nigeria shares with other
developing countries many demographic features
important to the persistent infection with H. pylori, e.g.,
low socioeconomic conditions and low standards of
hygiene, hence the high prevalence values found in this
study.
It is also possible that the variable antigenicity of the
different strains of H. pylori in the different studies
could contribute to the variation in sero-prevalence in
some of  the populations cited. For example, Mattson
et al35 found that infection with Helicobacter pylori gives
rise to specific B-cell responses against a number of
putative virulence factors of H. pylori, e.g., urease,
flagellin, and different bacterial surface antigens, locally
in the gastric mucosa. In that study, most of  the
infected subjects had IgA antibody secreting cells
(ASCs) reacting with H. pylori membrane proteins,
flagellin, and urease, while none of the non-infected
subjects had any detectable H. pylori-reactive ASCs.
Furthermore, half  of  the infected subjects also had
ASCs reacting with a Helicobacter-specific 26-kDa
protein, while only a few of them had ASCs reacting
with neutrophil-activating protein, the neuraminy-
llactose-binding haemagglutinin HpaA, or lipopoly-
saccharides purified from different H. pylori strains.
If the systemic response to H. pylori is same as this
pattern of local gastric mucosal response, it is possible
that anti-H. pylori IgA studies using one or two of this
variety of antigens will give different prevalence rates
and severity of histological parameters even in the same
cohort.
Akhiani et al,36 using laboratory mice demonstrated that
IgA deficient mice exhibited significantly less
colonization of the gastric mucosa and more severe
gastric inflammation than wild type mice. They
demonstrated that IgA antibodies counteracted gastric
inflammation.
Generally, secretory IgA antibody has been viewed as
an immune barrier which inhibits the entrance of
external foreign antigenic molecules. However, recent
studies 37, 38 have suggested two additional functions:
to neutralise intracellular microbial pathogens directly
within epithelial cells; and to bind antigens in the mucosa
and excrete the immune complexes through the
adjacent epithelium into the lumen to rid the body of
locally produced immune complexes.
This finding has also found support in human subjects
as demonstrated by Perez-Perez et al39, who found that
IgA responses to H. pylori whole cell sonicate and to
vac antigens were inversely related to chronic
inflammatory responses in American patients. Similarly,
Futagami et al40 demonstrated that strong serum IgA
responses were associated with type I gastritis
(superficial, mild) while weak signals were associated
with more severe gastritis (type II), in Japanese patients.
However, Kreuning et al41 who investigated the
relationship between IgG and IgA titres against the H.
pylori in serum and the severity of gastritis in
asymptomatic Dutch subjects found a direct
correlation between the IgA H. pylori antibody
absorbance index and the severity of gastritis in the
antrum and corpus of the stomach.
Unlike Perez-Perez et al39 and Akhiani et al36, on the
one hand, and Kreuning et al41 on the other hand, who
respectively found inverse and direct correlation
between IgA sero-positivity and degrees of mucosal
inflammation, we did not find such relationship.
When we examined our result from the point of view
of  studies which suggest that serum IgA counteracted
inflammation42, we found that the  anti H. pylori IgA
sero-positivity/sero-negativity ratio was greater among
patients having  low grade (mild)  chronic gastritis
(2.6:1) when compared with patients  having  higher
grades (moderate and severe) of chronic  gastritis
(1.9:1). Furthermore, we observed that the ratio of
subjects with lower grade (mild) inflammation
compared to higher grade inflammation (i.e. moderate
and severe inflammation) was slightly higher in IgA
positive than IgA negative patients (1.1: 0.82). These
differences in ratios and proportions were however
not statistically significant. We are of  the opinion that
the use of a larger cohort might help us to conclude
on the relationship between IgA serology and the
severity of  gastritis.
Our finding of no significant correlation between
neutrophilic infiltrate in chronic gastritis and the
presence of serum anti-H. pylori IgA antibody is in
agreement with the works of Kreuning et al29 and
Perez-Perez et al39 who also found no statistically
significant relationship between the two parameters.
Perhaps, this is the true picture. Otherwise, we may
need a larger cohort to prove the actual relationship
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between the parameters. It is noteworthy that the above
studies cited used small numbers of cohorts (48 and
82 respectively), similar to our number of cohorts of
64.
Furthermore, no relationship was established between
serum anti-H. pylori IgA antibody status and gastric
mucosal atrophy and intestinal metaplasia. This
contrasts with the findings of  Yamamoto et al43 and
Li et al44 who investigated the relationship between
severity of H. pylori gastritis and serum anti-H. pylori
antibodies in Japanese patients, and found a correlation
between these histological variables and IgA status.
Yamamoto et al43 found a significant association
between serum IgA titres and the development of
atrophic gastritis. Li et al44 ,on the other hand found
that in the absence of histological diagnosis of H. pylori
in the gastric mucosa in chronic gastritis anti-H. pylori
serum IgA is significantly higher in patients with severe
intestinal metaplasia than in those with mild intestinal
metaplasia. However, in the presence of H. pylori-like
organisms in the gastric mucosa no such relationship
was demonstrated. As is the case of the other
histological parameters, our use of a small cohort
might explain our inability to establish a relationship
between the variables in question.
However, a statistically significant relationship was
established between cagA status and serum IgA status.
This is in concordance with the findings of Rautelin et
al17 who found a direct relationship between IgA and
cag A statuses. With this finding of  significant cag-A
status relationship with IgA serology, one would expect
serum IgA positive status to be associated with more
intense mononuclear and neutrophilic infiltrates, higher
number and degrees of mucosal atrophy and intestinal
metaplasia.18-21   But this is not the case in this and
other studies.36, 39,40 The relationship between IgA status
and cag-A may, therefore, not be a simple one. It is
possible that other host and bacterial genetic factors
come into play to determine the severity and course
of  chronic gastritis. For example, Akhiani et al36
established that interleukin-10 (IL-10) polymorphism
may influence the course of the disease in IgA positive
and IgA- negative mice. Also, in the absence of  IL-12
(IL-12 polymorphism), the normal Th1 response to
H. pylori infection is known to be replaced by Th2
host immune activity. Th1 response is associated with
strong immune activity and mucosal damage while Th2
response appears to be protective against mucosal
damage.45-47 In addition, host genetic polymorphisms
in the IL-1ß gene and the IL-1 receptor-antagonist
gene (IL-1RN) have also been found to lead to
increased gastric mucosal levels of IL-1ß in individuals
infected with H. pylori48,49 and increased levels of
inammation. 48-52 The interplay between these host
genetic factors and the inflammatory mediators in the
determination of  host susceptibility to adverse
outcomes of Helicobacter pylori infection in our
population shall form the basis of  our future research
thrust using a larger cohort.
CONCLUSION
We conclude that the seroprevalence of  anti-H. pylori
IgA antibody is high in our environment pylori and
IgA sero-status does not discriminate between
symptomatic and asymptomatic individuals. Serum IgA
status may be associated with milder degrees of
gastritis in our patients but a larger cohorts is needed
to prove this. The serum H. pylori IgA activity in our
dyspeptic patients is associated with the cag-A status
of the H. pylori strain, however, the relationship
between cag-A and IgA statuses might be a complex
one.
ACKNOWLEDGEMENT:
The authors acknowledge the financial support of the
University of Ibadan, through the Senate Research
Grant #SRG/COM/2006/42A.
REFERENCES
1. Blaser MJ. Helicobacter pylori and the pathogenesis
of gastroduodenal inflammation. J Infect Dis 1990;
161: 626-33.
2. Rathbone BJ, Wyatt JI, Worsley BW, et al. Systemic
and local antibody responses to gastric Campylobacter
pyloridis in non-ulcer dyspepsia . Gut. 1986; 27:
642-7
3. Blaser MJ. Hypotheses on the pathogenesis and
natural history of Helicobacter pylori-induced
inflammation. Gastroenterology 1992; 102: 720-
727.
4. Kosunen TU, Seppälä K, Sarna S, Sipponen P.
Diagnostic value of  decreasing IgG, IgA, and IgM
antibody titres after eradication of Helicobacter pylori.
Lancet 1992; 339: 893-895
5. Perez-Perez GI, Dworkin BM, Chodos JE,
Blaser MJ. Campylobacter pylori antibodies in
humans. Ann Intern Med 1988; 109:11-17.
6. Campbell F, Bogomoletz V, William GT.
Tumours of  oesophagus and stomach. In: Fletcher
CDM (Ed) Diagnostic Histopathology of
Tumours. 2nd ed. Boston. Churchill Livingstone; 2000.
Pg. 332-339.
7. Dunn BE, Campbell GP, Perez-Perez GI, Blaser
MJ. Purification and characterization of  urease
from Helicobacter pylori. J. Biol. Chem. 1990;
265:9464-9469.
8. Dunn BE, Roop RM, Sung CC, Sharma SA,
Perez-Perez GI, Blaser MJ. Identification and
purification of a cpn60 heat shock protein
                                                   Annals of Ibadan Postgraduate  Medicine. Vol. 10 No. 1 June, 2012   22
homolog from Helicobacter pylori. Infect. Immun.
1992; 60:1946-1951.
9. Futagami S, Takahashi H, Norose Y, et al. Analysis
of immune response to Helicobacter pylori :
identication of the protein recognized by anti-
Helicobacter pylori antibodies from sera of patients
with gastroduodenal diseases. Jpn J Gastroenterol
1994; 91:2202–2213.
10. Czinn S, Carr H, SheZer L, et al. Serum IgG
antibody to the outer membrane proteins of
Campylobacter pylori in children with
gastroduodenal disease. J Infect Dis 1989; 159: 586–
589.
11. Cover TL, Blaser MJ. Purification and
characterization of the vacuolating toxin from
Helicobacter pylori J Biol Chem. 1992; 267:10570-
10575.
12. Leunk RP, Johnson PT, David BC, Kraft WG,
Morgan DR. Cytotoxic activity in broth-culture
filtrates of  Campylobacter pylori. J. Med. Microbiol.
1988; 26:93-99.
13. Tummuru MKR, Cover TL, Blaser MJ. Cloning
and expression of a high-molecular-mass major
antigen of Helicobacter pylori: evidence of linkage
to cytotoxin production. Infect. Immun. 1993;
61:1799-1809.
14. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM,
Blaser MJ, Smith PD. Soluble surface proteins from
Helicobacter pylori activate monocytes/macrophages
by a lipopolysaccharide-independent mechanism.
J. Clin. Invest. 1991; 87(3):894-900.
15. Mai UEH, Perez-Perez GI, Allen JB, Wahl SM,
Blaser MJ, Smith PD. Surface proteins from
Helicobacter pylori exhibit chemotactic activity for
human leukocytes and are present in gastric
mucosa. J. Exp. Med. 1992; 175:517-525.
16. Lee A, Fox J, Hazell S. Pathogenicity of Helicobacter
pylori: a perspective. Infect. Immun. 1993; 61:1601-
1610.
17. Rautelin HI, Oksanen AM, Karttunen RA, et al.
Association of CagA positive infection with
Helicobacter pylori antibodies of  IgA class. Ann Med
2000; 32: 652-656.
18. Bhat N, Gaensbauer J, Peek RM, et al. Local and
Systemic Immune and Inflammatory Responses
to Helicobacter pylori Strains. Clin Diagn Lab Immunol
2005; 12 (12):1393-1400.
19. Oksanen A, Sipponen P, Karttunen R, et al.
Atrophic gastritis and Helicobacter pylori infection
in outpatients referred for gastroscopy. Gut 2000;
46(4): 460–463.
20. Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM,
Blaser MJ. Helicobacter pylori and Atrophic
Gastritis: Importance of  the cagA Status. J Natl
Cancer Inst, 1995 87 (23): 1777-1780.
21. Peek RM Jr, Miller GG, Tham KT, et al.
Heightened inflammatory response and cytokine
expression in vivo to cagA+ Helicobacter pylori
strains. Lab Invest. 1995; 73(6):760-770.
22. Holcombe C, Omotara BA, Eldridge J, Jones
DM. H. pylori the most common infection in
Africa: A random Serological study. Am. J.
Gastroenterol. 1992; 87: 28-30.
23. Oluwasola AO, Ola SO, Saliu L, Solanke TF.
Helicobacter pylori infection in South Nigerians: a
serological study of dyspeptic patients and healthy
individuals. West Afr J Med. 2002; 21(2):138-141.
24. Ugwuja EI, Ugwu NC. Helicobacter pylori in
uninvestigated dyspepsia in primary cares in
Abakaliki, Nigeria. Online J. Health Allied Sci. 2007;
1: 4. (s)
25. Nwodo EN, Yakubu SE,  Jatau ED,  Yabaya A,
Seroprevalence of Helicobacter pylori Infection in
Patients with Gastritis and Peptic Ulcer Disease in
Kaduna, Kaduna State, Nigeria. Afr J. Basic Appl.
Sci., 2009; 1 (5-6): 123-128.
26. Ophori EA, Isibor C, Onemu SO, Johnny EJ,
Immunological response to Helicobacter pylori
among healthy volunteers in Agbor, Nigeria. Asian
Pacific J Trop Dis 2011; 38-40
27. Öztürk S, Serinsöz E, Kuzu I, et al. The Sydney
System in the assessment of  gastritis: Inter-observer
agreement. Turk J Gastroenterol 2001; 12(1):36-39.
28. Chen XG, Correa P, Offerhaus J, et al.
Ultrastructure of the gastric mucosa harbouring
Campylobacter-like organisms. Am J Clin Pathol
1986; 86:575–582.
29. Isaacson P. Immunoperoxidase study of  the
secretory immunoglobulin system and lysozyme
in normal and diseased gastric mucosa. Gut. 1982;
23:578-588.
30. Valle J, Seppala K, Sipponen P, Kosunen T.
Disappearance of gastritis after eradication of
Helicobacter pylori. A morphometric study. Scand.
J. Gastroenterol. 1991; 26:1057-1065.
31. Kosunen TV, Seppala K, Sarna S, Sipponen P.
Diagnostic value of  decreasing IgG, IgA, and IgM
antibody titres after eradication of Helicobacter pylori.
Lancet 1992; 339:893-895.
32. Aromaa A, Kosunen TU,  Knekt P, et al.
Circulating Anti-Helicobacter pylori Immunoglobulin
A Antibodies and Low Serum Pepsinogen I Level
Are Associated with Increased Risk of Gastric
Cancer. Am J Epidemiol 1996; 144(2): 142-149.
33. Granberg C, Mansikka A, Lehtonen OP, et al.
Diagnosis of Helicobacter pylori infection by using
pyloriset EIA-G and EIA-A for detection of
serum immunoglobulin G (IgG) and IgA
antibodies. J Clin Microbiol., 1993; 31(6):1450-
1453.
                                                   Annals of Ibadan Postgraduate  Medicine. Vol. 10 No. 1 June, 2012   23
34. Kosunen TU,  Seppälä K, Sarna S, et al.
Association of Helicobacter pylori Ig A antibodies
with the risk of peptic ulcer disease and gastric
cancer. World J Gastroenterol, 2005; 11 (43): 6871-
6874.
35. Mattsson A, Quiding-Järbrink M, Lönroth H,
Hamlet A,  Ahlstedt I, Svennerholm A-M.
Antibody-Secreting Cells in the Stomachs of
Symptomatic and Asymptomatic Helicobacter pylori-
Infected Subjects. Infect Immun. 1998; 66(6): 2705–
2712.
36. Akhiani AA, Stensson A, Schn K, Lycke NY. IgA
Antibodies Impair Resistance against Helicobacter
pylori Infection: Studies on Immune Evasion in IL-
10-Deficient Mice. J Immunol, 2005; 174; 8144-
8153.
37. Kaetzel CS, Robinson JK, Chintalacharuvu KR,
et al. The polymeric immunoglobulin receptor
(secretory component) mediates transport of
immune complexes across epithelial cells: a local
defense function for IgA. Proc Natl Acad Sci USA.
1991; 88:8796–8800.
38. Mazanec MB, Nedrud JG, Kaetzel CS, et al.  A
three-tiered view of the role of IgA in mucosal
defense. Immunol Today. 1993; 14:430–435.
39. Perez-Perez GI, Brown WR, Cover TL, Dunn
BE, Cao P, Blaser MJ. Correlation between
serological and mucosal inflammatory responses
to Helicobacter pylori. Clinical and Diagnostic
Laboratory Immunology, 1994, 1(3): 325-329.
40. Futagami S, Takahashia H, Norose Y,
Kobayashia M. Systemic and local immune
responses against Helicobacter pylori urease in
patients with chronic gastritis: distinct IgA and IgG
productive sites. Gut 1998; 43:168-175
41. Kreuning J, Lindeman J, Biemond I, Lamers CB.
Relation between IgG and IgA antibody titres
against Helicobacter pylori in serum and severity of
gastritis in asymptomatic subjects. J Clin Pathol.
1994; 47(3):227-231.
42. Akhiani AA, Schon K, Franzen LE, Pappo J,
Lycke N. Helicobacter pylori-specific antibodies
impair the development of gastritis, facilitate
bacterial colonization, and counteract resistance
against infection. J. Immunol. 2004; 172: 5024-5033.
43. Yamamoto I, Fukuda Y, Mizuta T, Fukada M,
Nishigami T, Shimoyama T. Serum anti-Helicobacter
pylori antibodies and gastritis. J Clin Gastroenterol.
1995; 21 Suppl 1:S164-168.
44. Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter
pylori immunoglobulin G (IgG) and IgA antibody
responses and the value of clinical presentations
in diagnosis of H. pylori infection in patients with
precancerous lesions. World J Gastroenterol. 2003;
9(4):755-758.
45. Schnare M, Barton GM, Holt AC, Takeda K,
Akira S, Medzhitov R. Toll-like receptors control
activation of  adaptive immune responses. Nature
Immunology, 2001; 2:947-950.
46. Sutton P, Kolesnikowt T, Danon S, Wilson J, Lee
A. Dominant Non-responsiveness to Helicobacter
pylori infection is associated with production of
interleukin 10 but not gamma interferon. Infect
Immun, 2000; 68:4802-4804.
47. Mythies LE, Waites KB, Lindsey JR, Harris PR,
Ghiara P, Smith PD. Helicobacter pylori-induced
mucosal inflammation is Th1 mediated and
exacerbated in IL-4, but not IFN-gamma, gene-
deficient mice. J Immunol. 2000; 165: 1022-1029.
48. Hwang IR, Kodama T, Kikuchi S, et al. 2002.
Effect of interleukin 1 polymorphisms on gastric
mucosal interleukin 1 beta production in
Helicobacter pylori  infection. Gastroenterolog y
123:1793–1803
49. Rad R, Dossumbekova A, Neu B, et al. Cytokine
gene polymorphisms inuence mucosal cytokine
expression, gastric inammation, and host specic
colonisation during Helicobacter pylori infection. Gut
2004; 53:1082–1089
50. Furuta T, El-Omar EM, Xiao F, et al. Interleukin
1 beta polymorphisms increase risk of
hypochlorhydria and atrophic gastritis and reduce
risk of duodenal ulcer recurrence in Japan.
Gastroenterology 2002; 123:95–105
51. Machado JC, Figueiredo C, Canedo P, et al. A
proinammatory genetic prole increases the risk of
chronic atrophic gastritis and gastric carcinoma.
Gastroenterology 2003; 125:364–371
52. Rad R, Prinz C, Neu B, et al. Synergistic effect of
Helicobacter pylori virulence factors and interleukin-
1 polymorphisms for the development of severe
histological changes in the gastric mucosa. J. Infect.
Dis. 2003; 188:272–281.
                                                   Annals of Ibadan Postgraduate  Medicine. Vol. 10 No. 1 June, 2012   24
